FTRE
Price
$16.45
Change
+$0.89 (+5.72%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.56B
55 days until earnings call
Intraday BUY SELL Signals
NTLA
Price
$15.23
Change
-$0.52 (-3.30%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.13B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FTRE vs NTLA

FTRE vs NTLA Comparison Chart in %
View a ticker or compare two or three
VS
FTRE vs. NTLA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (FTRE: $15.55 vs. NTLA: $15.75)
Brand notoriety: FTRE and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 117% vs. NTLA: 54%
Market capitalization -- FTRE: $1.47B vs. NTLA: $2.13B
FTRE [@Biotechnology] is valued at $1.47B. NTLA’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, both FTRE and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • FTRE’s TA Score: 4 bullish, 5 bearish.
  • NTLA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а -6.49% price change this week, while NTLA (@Biotechnology) price change was +5.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 17, 2026.

NTLA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.13B) has a higher market cap than FTRE($1.56B). NTLA YTD gains are higher at: 75.195 vs. FTRE (-9.855). FTRE has higher annual earnings (EBITDA): -280.8M vs. NTLA (-405.09M). NTLA has more cash in the bank: 376M vs. FTRE (148M). NTLA has less debt than FTRE: NTLA (80.5M) vs FTRE (1.12B). FTRE has higher revenues than NTLA: FTRE (2.71B) vs NTLA (66.1M).
FTRENTLAFTRE / NTLA
Capitalization1.56B2.13B73%
EBITDA-280.8M-405.09M69%
Gain YTD-9.85575.195-13%
P/E RatioN/AN/A-
Revenue2.71B66.1M4,098%
Total Cash148M376M39%
Total Debt1.12B80.5M1,389%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTRENTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTKI20.140.17
+0.84%
First Trust Small Cap Buywrite Income ETF
BSMQ23.550.02
+0.08%
Invesco BulletShares 2026 Muncpl Bd ETF
SPGM85.92-0.16
-0.19%
State Street® SPDR® Ptf MSCIGlbStkMktETF
ASMG62.40-0.14
-0.22%
Leverage Shares 2X Long Asml Daily ETF
DXD17.71-0.08
-0.45%
ProShares UltraShort Dow30

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+1.57%
BEAM - FTRE
43%
Loosely correlated
+4.07%
RXRX - FTRE
42%
Loosely correlated
-2.01%
NTLA - FTRE
40%
Loosely correlated
+0.51%
TECH - FTRE
38%
Loosely correlated
-3.97%
MRVI - FTRE
37%
Loosely correlated
+1.15%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+0.51%
VCYT - NTLA
69%
Closely correlated
-0.82%
BEAM - NTLA
59%
Loosely correlated
+4.07%
EDIT - NTLA
56%
Loosely correlated
+3.53%
CRSP - NTLA
56%
Loosely correlated
+0.50%
AXON - NTLA
55%
Loosely correlated
-3.16%
More